House of Lords ageing inquiry: written evidence

Increasing health span has been adopted as a policy objective by the UK Government in the Industrial Strategy’s "Ageing Society" Grand Challenge, which aims to ensure that people can enjoy at least 5 extra healthy, independent years of life by 2035. This House of Lords inquiry will seek to determine whether the Government's ambition to increase health span is achievable in principle, and which approaches may be most successful in practice.

We have focused our response on embedding research in the NHS, addressing multi-morbidity and polypharmacy, and implementing pharmacogenomics, which together should lead to improved patient safety in the NHS. These are all areas in which clinical pharmacology can help make an impact on the health of an ageing population.

Read our response.

Published: 22 Oct 2019 in